| |
| |
|
| Insider
Information: |
Martin John C |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,895,138 |
|
|
Indirect Shares
|
2,684,281 |
|
|
| Direct
Value |
$187,779,289 |
|
|
|
Indirect Value
|
$47,355,030 |
|
|
| Total
Shares |
5,579,419 |
|
|
| Total
Value |
$235,134,319 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-10-10 |
4 |
S |
$40.00 |
$3,693,169 |
D/D |
(92,320) |
1,949,215 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-10-10 |
4 |
OE |
$8.22 |
$758,760 |
D/D |
92,320 |
2,041,535 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-12-01 |
4 |
OE |
$8.22 |
$367,545 |
D/D |
44,720 |
1,993,935 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-12-01 |
4 |
AS |
$40.01 |
$1,789,068 |
D/D |
(44,720) |
1,949,215 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-12-02 |
4 |
OE |
$8.22 |
$10,684 |
D/D |
1,300 |
1,950,515 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-12-02 |
4 |
AS |
$40.00 |
$52,000 |
D/D |
(1,300) |
1,949,215 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-12-05 |
4 |
AS |
$40.00 |
$1,852,000 |
D/D |
(46,300) |
1,949,215 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-12-05 |
4 |
OE |
$8.22 |
$380,530 |
D/D |
46,300 |
1,995,515 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-02-07 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,094,665 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-02-07 |
4 |
AS |
$54.92 |
$8,013,529 |
D/D |
(145,450) |
1,949,215 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-03-01 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,094,665 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-03-01 |
4 |
AS |
$46.23 |
$6,723,804 |
D/D |
(145,450) |
1,949,215 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-03-12 |
4 |
D |
$46.16 |
$1,616,062 |
D/D |
(35,010) |
1,989,205 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
2,024,215 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-04-02 |
4 |
AS |
$48.38 |
$7,036,842 |
D/D |
(145,450) |
1,989,205 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-04-02 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,134,655 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-05-01 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,134,655 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-05-01 |
4 |
AS |
$51.71 |
$7,521,496 |
D/D |
(145,450) |
1,989,205 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-06-01 |
4 |
AS |
$48.65 |
$7,091,410 |
D/D |
(145,450) |
1,989,205 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-06-01 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,134,655 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-06-29 |
4 |
A |
$29.02 |
$21,271 |
D/D |
733 |
1,989,938 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-07-02 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,135,388 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-07-02 |
4 |
AS |
$51.32 |
$7,464,683 |
D/D |
(145,450) |
1,989,938 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-08-01 |
4 |
AS |
$53.84 |
$7,854,091 |
D/D |
(145,450) |
1,989,938 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2012-08-01 |
4 |
OE |
$8.94 |
$1,300,687 |
D/D |
145,450 |
2,135,388 |
0 |
- |
|
367 Records found
|
|
Page 4 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
